Results 241 to 250 of about 32,363 (292)

A digital diagnostic pathway for heart failure: an economic evaluation. [PDF]

Cost Eff Resour Alloc
Mcmeekin N, Davies A, Petrie MC, Campbell RT, Lowe DJ, Murphy CL, Macklin L, Brooksbank K, Wu O.   +8 more
europepmc   +1 more source

The impact of new tetralogy drugs on ventricular remodeling in heart failure patients: a systematic review and network meta-analysis. [PDF]

BMC Cardiovasc Disord
Wang XW, Li H, Wang GQ, Sheng YN, Wang X, Pan H, Wang ZH, Zhang W, Shang YY, Zhong M.   +9 more
europepmc   +1 more source

Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: Insights from the FIGHT trial [PDF]

, 2018
Ambrosy, Andrew P, Borlaug, Barry A, Cooper, Lauren B, DeVore, Adam D, Felker, Gary Michael, Groake, John D, Hernandez, Adrian F, Lala, Anuradha, Margulies, Kenneth B, McNulty, Steven E, Mentz, Robert J, Sharma, Abhinav, Vader, Justin, Velazquez, Eric J   +13 more
core   +1 more source

Effect of tofogliflozin on cardiac sympathetic nerve activity in type 2 diabetes mellitus patients with heart failure (TARGET-HF): rationale and design of the single-arm intervention trial. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Okumura T, Bando YK, Isobe S, Fujita N, Sera F, Ikeda Y, Yajima A, Nagai T, Hiraiwa H, Morimoto R, Anzai T, Node K, Ako J, Sakata Y, Murohara T.   +14 more
europepmc   +1 more source

Delayed Severe Heart Failure Despite Successful Graves' Disease Management. [PDF]

Clin Case Rep
Nakashima H, Kamihara T, Omura T, Shimizu A.   +3 more
europepmc   +1 more source

Effects of SGLT2 Inhibitors on Clinical Outcomes, Symptoms, Functional Capacity, and Cardiac Remodeling in Heart Failure: A Comprehensive Systematic Review and Multidomain Meta-Analysis of Randomized Trials. [PDF]

J Clin Med
Bodea OM, Serban S, Craciun ML, Mateescu DM, Florescu E, Muresan CO, Cotet IG, Badalica-Petrescu M, Munteanu A, Velimirovici D, Kundnani NR, Dragan SR.   +11 more
europepmc   +1 more source

Machine Learning-Driven Prediction of One-Year Readmission in HFrEF Patients: The Key Role of Inflammation

Fanghui Ma, Yue Hu, Ping Han, Yan Qiu, Ying Liu, Jingjing Ren   +5 more
openalex   +2 more sources

Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry. [PDF]

Eur J Heart Fail
Inciardi RM, Volterrani M, Savarese G, Vaduganathan M, Oriecuia C, Lombardi CM, Gussago C, Agostoni P, Ameri P, Armentaro G, Arzilli C, Aspromonte N, Attanasio A, Badagliacca R, Barbieri L, Bocchino PP, Bursi F, Cameli M, Canonero M, Campodonico JS, Capovilla T, Carluccio E, Carugo S, Castiglione V, Catapano D, Cipriani M, Correale M, D'Amario D, De Caterina R, De Ferrari GM, D'Elia E, Di Odoardo L, Emdin M, Falco L, Ferrante G, Fornaro A, Fornaro P, Guastamiglio G, Guazzi M, Iacoviello M, Imazio M, Incaminato E, La Rovere MT, Leonardi S, Maccallini M, Mandoli GE, Masarone D, Masetti M, Mazzoni A, Mazzotta M, Merlo M, Moschini L, Novarese F, Palazzuoli A, Pastore MC, Patti G, Pedretti RFE, Pidello S, Piepoli MF, Pinto G, Potena L, Raineri C, Rubbo FM, Sabatino M, Salzano A, Sciacqua A, Senni M, Severino P, Sinagra G, Sposato B, Taddei S, Valleggi A, Vignati C, Vizza D, Specchia C, Rosano G, Metra M, OPTIPHARM‐HF investigators.   +77 more
europepmc   +1 more source

Biomarkers of Cardiac Metabolic Flexibility in Health, HFrEF and HFpEF. [PDF]

Int J Mol Sci
Yun HR, Singh MK, Han S, Ranbhise JS, Ha J, Kim SS, Kang I.   +6 more
europepmc   +1 more source

A prospective randomized controlled study of multi-intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure and reduced ejection fraction (PRIME-HFrEF) trial: Rationale and design

Xin Gong, Yuheng Jiao, Hu Ha, Rongzhen Zhang, Wenwen Jia, Jun Zhao, Zhongmin Liu, Yuanfeng Xin, Wei Han   +8 more
openalex   +1 more source